Match tier Institution-verified
Presence Not recently confirmed
Last published 2026
Sources Institutional record
Refreshed 2026-10-07

Marcelo Puppo Bigarella

Sourced from institutional research profiles (UAMS TRI or ARA).

Role not yet determined

Also affiliated: University of Wisconsin System (2024); University of Wisconsin–Madison (2023–2026); Universidade de São Paulo (2022)

2 h-index 22 pubs 18 cited

  • Humans
  • Male
  • Neoplastic Cells, Circulating
  • Prostatic Neoplasms, Castration-Resistant
  • Multiparametric Magnetic Resonance Imaging
  • Prostate
  • Prostatic Neoplasms
  • 5-alpha Reductase Inhibitors
  • Acetylation
  • Histones
  • p300-CBP Transcription Factors
  • Sirtuin 2
  • Aged
  • Middle Aged
  • Retrospective Studies

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Marcelo Bigarella's research focuses on the molecular mechanisms and diagnostic approaches for prostate cancer. He has developed multiplex assays to assess activated histone modifiers, specifically p300/CBP, in circulating tumor cells, aiming to improve the understanding and detection of advanced prostate cancer, including castration-resistant forms. His work also investigates the impact of therapeutic agents, such as 5α-reductase inhibitors, on prostate cancer characteristics as observed through multiparametric MRI. Bigarella has explored the role of PSA kinetics in men with negative MRI-targeted prostate biopsies and examined treatment considerations for prostate cancer patients with neurogenic bladders.

His publications also extend to broader cancer biology principles, including the stem cell origin of cancer and strategies for chemoprevention and maintenance therapy. Bigarella collaborates with researchers at the University of Arkansas for Medical Sciences, including Shi-Ming Tu, Jaskirat Sethi, Sunny Singh, and Yusra B. Medik, with whom he has co-authored publications.

Metrics

  • h-index: 2
  • Publications: 22
  • Citations: 18

Selected Publications

  • Addition of 18F-DCFPyL PSMA PET to MRI to avoid unnecessary biopsy in men on active surveillance: Final results from a phase II diagnostic trial (PROMPT). (2026)
    Journal of Clinical Oncology 1 citation DOI OpenAlex
  • Pathologic findings and clinical outcomes after immune checkpoint blockade in renal cell carcinoma patients undergoing deferred consolidative nephrectomy. (2026)
    Journal of Clinical Oncology DOI OpenAlex
  • Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care (2025)
    Cancers 2 citations DOI OpenAlex
  • Multidisciplinary management of nonmetastatic locally advanced prostate cancer (T3-4N0M0) (2025)
    Surgical Oncology Insight DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

7 Collaborators 2 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics